pharma · Breast Cancer · Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease
Pierre Fabre Medicament
Pierre Fabre Medicament clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
LAVAUR, FR HQ
176 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- LAVAUR, FR
- Employees
- 176
- Programs
- 8
- Drugs
- 13
- Patents
- 0
Pierre Fabre Medicament projects
3 ClinicalTrials.gov programs sponsored by Pierre Fabre Medicament.
Pierre Fabre Medicament has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Pierre Fabre Medicament have?
3 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.